Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still have a desire to back companies working on RIPK1 inhibitors despite setbacks for GSK in ...

Sonde Health has launched a new version of its vocal biomarker technology – which aims to diagnose diseases from a person's voice patterns – that it says can be used to monitor mental health ...